Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling-Reference-Cited by-同舟云学术

Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling

Published:2013-08-06 Issue:1 Volume:231 Page:21-34
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Bashashati Ali¹,Ha Gavin¹,Tone Alicia²,Ding Jiarui¹³,Prentice Leah M²,Roth Andrew¹,Rosner Jamie¹,Shumansky Karey¹,Kalloger Steve²,Senz Janine²,Yang Winnie²,McConechy Melissa²,Melnyk Nataliya²,Anglesio Michael²,Luk Margaret TY⁴,Tse Kane⁵,Zeng Thomas⁵,Moore Richard⁵,Zhao Yongjun⁵,Marra Marco A⁵,Gilks Blake⁶,Yip Stephen⁷,Huntsman David G²⁷,McAlpine Jessica N⁸,Shah Sohrab P¹⁷

Affiliation:

1. Department of Molecular Oncology British Columbia Cancer Agency Vancouver Canada

2. Centre for Translational and Applied Genomics British Columbia Cancer Agency Vancouver Canada

3. Department of Computer Science University of British Columbia Vancouver Canada

4. Department of Anatomical Pathology Vancouver General Hospital Vancouver Canada

5. Canada's Michael Smith Genome Sciences Centre British Columbia Cancer Agency Vancouver Canada

6. Genetic Pathology Evaluation Centre Vancouver General Hospital Vancouver Canada

7. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver Canada

8. Department of Gynecology and Obstetrics University of British Columbia Vancouver Canada

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.4230

Reference40 articles.

1. Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results

2. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

3. Integrated genomic analyses of ovarian carcinoma

4. Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada

5. Frequency of BRCA1 Dysfunction in Ovarian Cancer

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress in intratumoral heterogeneity and clinical significance of ovarian cancer;Medicine;2024-01-26

2. Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer;Scientific Reports;2023-12-11

3. Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs;Current Oncology;2023-11-29

4. Multidimensional progressive single‐cell sequencing reveals cell microenvironment composition and cancer heterogeneity in lung cancer;Environmental Toxicology;2023-11-13

5. Mutation divergence over space in tumour expansion;Journal of The Royal Society Interface;2023-11